To define the contribution of Akt to PDK1 actions along aging and in AD, a longitudinal study was conducted in which we genetically manipulated the levels of Akt activity by employing the PDK1K465E/K465E knock-in mice with reduced Akt activation but otherwise intact PDK1 signaling. The gene discussed is PDK1; the disease is Alzheimer disease.